ImmunityBio (IBRX) Enterprise Value (2015 - 2026)
ImmunityBio's Enterprise Value came in at $8.87 billion for Q2 2026, up 291.7% from $2.26 billion a year earlier and up 15.9% from the prior quarter.
Powered by 
Analysis
ImmunityBio (IBRX) Enterprise Value (2015 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, ImmunityBio reported Enterprise Value of $7.99 billion, up 315.5% year-over-year; for FY2025, it was $1.76 billion, up 7.6% from FY2024.
- Enterprise Value carries a five-year compound annual growth rate of 6.5% (FY2020 to FY2025).
- Going back by year, Enterprise Value was $1.64 billion in FY2024 (-28.5%), $2.29 billion in FY2023 (+12.8%), $2.03 billion in FY2022 (-3.4%) and $2.1 billion in FY2021 (+63.3%).
- The Q2 2026 figure represents the highest quarterly Enterprise Value since Q1 2021.
- Year-over-year, Enterprise Value has increased for three consecutive quarters, with growth averaging 83.5% over the last eight quarters.
- The fastest year-over-year change in Enterprise Value over five years came in Q3 2021 (growth of 520.1%), and the weakest in Q1 2022 (a decline of 77.4%).
- Business Quant data shows IBRX's Enterprise Value at $7.65 billion (Q1 2026), $1.76 billion (Q4 2025) and $2.17 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | ImmunityBio | 9.07 Bn | 7.83 Bn | 50.94 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.87 Bn |
| Mar 31, 2026 | 7.65 Bn |
| Dec 31, 2025 | 1.76 Bn |
| Sep 30, 2025 | 2.17 Bn |
| Jun 30, 2025 | 2.26 Bn |
| Mar 31, 2025 | 2.51 Bn |
| Dec 31, 2024 | 1.64 Bn |
| Sep 30, 2024 | 2.46 Bn |
| Jun 30, 2024 | 4.16 Bn |
| Mar 31, 2024 | 3.47 Bn |
| Dec 31, 2023 | 2.29 Bn |
| Sep 30, 2023 | 653.53 Mn |
| Jun 30, 2023 | 1.18 Bn |
| Mar 31, 2023 | 673.25 Mn |
| Dec 31, 2022 | 2.03 Bn |
| Sep 30, 2022 | 1.88 Bn |
| Jun 30, 2022 | 1.40 Bn |
| Mar 31, 2022 | 2.04 Bn |
| Dec 31, 2021 | 2.10 Bn |
| Sep 30, 2021 | 3.76 Bn |
API Access
ImmunityBio Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=IBRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "IBRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=IBRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();